G1 Therapeutics, Inc. (GTHX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 7.15 |
| Open | 7.15 |
| Day High | 7.16 |
| Day Low | 7.14 |
| 52-Week High | 7.19 |
| 52-Week Low | 1.08 |
| Volume | 1.1M |
| Average Volume | 2.23M |
| Market Cap | 377.75M |
| PE | -8.33 |
| EPS | -0.86 |
| Moving Average 50 Days | 5.57 |
| Moving Average 200 Days | 4.01 |
| Change | 0.01 |
Data not available
Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer
GlobeNewswire Inc.
Sep 18, 2024 12:54 PM GMT
- Transaction Will Maximize the Access and Uptake of COSELA® (trilaciclib), the First and Only Proactive Multilineage Myeloprotection Agent - - G1 Stockholders to Receive U.S. $7.15 Per Share in Cash - HOLBAEK, Denmark and RESEARCH TRIANGLE PARK, N.C